HIV treatment cascade in regions of Peru with the highest HIV prevalence

Nora Reyes, Carlos Benites, Lisset García-Fernández, Maria Calderon*, Fabián Fiestas, Ruben Vasquez-Becerra, Eva Aranda, Carlos A. Yabar, Angélica García, Cesar Ramal, Ericson L. Gutiérrez

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

Resumen

Objectives: To describe the HIV treatment cascade and care continuum in regions of highest HIV prevalence in Peru. Methods: An observational longitudinal study was carried out in 14 tertiary hospitals in Peru. These are the main hospitals that administer antiretroviral treatment (ART) in the regions that represent approximately 95% of reports of HIV/AIDS cases in Peru in 2013. We included individuals older than 18 years newly diagnosed with HIV from 1 January 2011 to 31 December 2012. Medical records were reviewed until 2015. Results: A total of 2119 people living with HIV (PLHIV) were identified in the selected health facilities (mean age = 35.26 years, 78% male). 97.25% [1845/1897; 95% confidence interval (CI): 96.4–97.9%] of the patients attended the consultation at least once during the follow-up, but only 64.84% (885/1365; 95% CI: 62.2–67.4%) attended within a month after the diagnosis. After starting ART, 74.63% (95% CI: 71.9–77.2%) of PLHIV remained in healthcare. Regardless of the time after diagnosis, 88.40% (1837/2078; 95% CI: 86.9–89.7%) of PLHIV started ART during the observation time. However, 78.68% (95% CI: 76.8–80.4%) did so during the first post-treatment year and only 28.88% (95% CI: 27.9–31.9%) after 1 month. After starting treatment, it was observed that 51.60% (95% CI: 49.2–54%) of PLHIV reached viral suppression during the follow-up period. Conclusions: Further analysis and improvements in the definition of indicators are required to achieve conclusive results; however, these data will give us a general understanding of the progress of Peruvian health policies in achieving the goal established by the WHO.

Idioma originalInglés
Páginas (desde-hasta)620-627
Número de páginas8
PublicaciónHIV Medicine
Volumen24
N.º5
DOI
EstadoPublicada - may. 2023

Huella

Profundice en los temas de investigación de 'HIV treatment cascade in regions of Peru with the highest HIV prevalence'. En conjunto forman una huella única.

Citar esto